Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Thomas Ondet"'
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Cutaneous adverse drug reactions (CADR) associated with oncology therapy involve 45–100% of patients receiving kinase inhibitors. Such adverse reactions may include skin inflammation, infection, pruritus and dryness, symptoms th
Externí odkaz:
https://doaj.org/article/92101855f9264dff9ae6227bd4a8a7cc
Publikováno v:
JID Innovations, Vol 1, Iss 2, Pp 100009- (2021)
EGFR inhibitors used in oncology therapy modify the keratinocyte differentiation processes, impairing proper skin barrier formation and leading to cutaneous adverse drug reactions. To uncover the molecular signatures associated with cutaneous adverse
Externí odkaz:
https://doaj.org/article/19c458bef6b84fc38a63ef0db8e0d9b8
Publikováno v:
JID Innovations
JID Innovations, Vol 1, Iss 2, Pp 100009-(2021)
JID Innovations, Vol 1, Iss 2, Pp 100009-(2021)
EGFR inhibitors used in oncology therapy modify the keratinocyte differentiation processes, impairing proper skin barrier formation and leading to cutaneous adverse drug reactions. To uncover the molecular signatures associated with cutaneous adverse
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Background Cutaneous adverse drug reactions (CADR) associated with oncology therapy involve 45–100% of patients receiving kinase inhibitors. Such adverse reactions may include skin inflammation, infection, pruritus and dryness, symptoms that can si
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB22
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB22
Autor:
Béatrice Muscatelli-Groux, Sacha Robert, Jean Alexis Grimaud, Cédric Coulouarn, Thomas Ondet, Thomas Gicquel, Vincent Lagente, Aude Bodin
Publikováno v:
Clinical and Experimental Pharmacology and Physiology
Clinical and Experimental Pharmacology and Physiology, Wiley, 2017, 44 (7), pp.827-838. ⟨10.1111/1440-1681.12765⟩
Clinical and Experimental Pharmacology and Physiology, 2017, 44 (7), pp.827-838. ⟨10.1111/1440-1681.12765⟩
Clinical and Experimental Pharmacology and Physiology, Wiley, 2017, 44 (7), pp.827-838. ⟨10.1111/1440-1681.12765⟩
Clinical and Experimental Pharmacology and Physiology, 2017, 44 (7), pp.827-838. ⟨10.1111/1440-1681.12765⟩
International audience; Toll-like receptors (TLRs) are expressed in the skin and airway epithelial tissues, which are the most important sites of host-pathogen interactions. TLRs recognize the 3-D structures of pathogen-associated molecules and are t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b32036b757854e17741917b1a14663b1
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01560560/document
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01560560/document
Publikováno v:
Journal of Investigative Dermatology. 139:S249
Autor:
Stamatas, Georgios N.1 (AUTHOR) georgios.stamatas@outlook.com, Roux, Pierre‐Francois1 (AUTHOR), Boireau‐Adamezyk, Elise1 (AUTHOR), Lboukili, Imane1 (AUTHOR), Oddos, Thierry1 (AUTHOR)
Publikováno v:
Experimental Dermatology. Sep2023, Vol. 32 Issue 9, p1420-1429. 10p.